Identifying Drug Targets in Pancreatic Ductal Adenocarcinoma Through Machine Learning, Analyzing Biomolecular Networks, and Structural Modeling
Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related death and has an extremely poor prognosis. Thus, identifying new disease-associated genes and targets for PDAC diagnosis and therapy is urgently needed. This requires investigations into the underlying molecular m...
Main Authors: | Wenying Yan, Xingyi Liu, Yibo Wang, Shuqing Han, Fan Wang, Xin Liu, Fei Xiao, Guang Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00534/full |
Similar Items
-
MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
by: Yu. Yu. Rakina, et al.
Published: (2017-09-01) -
Hyperdense Pancreatic Ductal Adenocarcinoma: Clinical Characteristics and Proteomic Landscape
by: He Xu, et al.
Published: (2021-02-01) -
Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma
by: Hiromitsu Hayashi, et al.
Published: (2021-07-01) -
Metastatic pancreatic ductal adenocarcinoma in a teenage girl: A rare disease
by: Sutaryo Sutaryo, et al.
Published: (2020-11-01) -
Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma
by: Dingyuan Hu, et al.
Published: (2019-02-01)